Eli Lilly is reinventing the pharma business
The world’s largest drugmaker is betting big on preventive medicines—and learning from big tech
Read the full article2d agoen
You might also wanna read
Wall Street Is Betting on Eli Lilly’s GLP-1 Portfolio — It’s Missing the $1 Trillion Opportunity
The pharmaceutical industry is entering a new era where biology and artificial intelligence are converging. Drug discovery, once a slow proc
24/7 Wall St.·9d ago
Big Pharma is making big moves
Big Pharma is hunting for its next blockbuster.
brewmarkets.com·1d ago
Eli Lilly buys psychedelic biotech backed by Peter Thiel
World’s biggest drugmaker agrees to buy Ataibeckley for up to $3.8bn
ft.com·1d ago
Is This Disturbing Trend Bad News for Eli Lilly in the Billion-Dollar Obesity Drug Market?
Eyes are on the rollout of Lilly's new weight loss pill.
Bars·3d ago
Wegovy Pill Just Changed the GLP-1 Market. Here's Why Eli Lilly Stock Could Still Win
Novo Nordisk is finally getting one up on its biggest rival.
Bars·14h ago
Eli Lilly’s Michael Kopach says retatrutide leads in obesity treatment and CMC innovation
The pharma company’s latest peptide is so effective, it’s raising eyebrows among medical professionals.
bioprocessintl.com·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.